REGISTERED
on 12 Apr 2022
Last Applicant/ Owned by
511 Benedict Ave.
Tarrytown
NY
10591
Serial Number
90976382 filed on 30th Sep 2020
Registration Number
6703152 registered on 12th Apr 2022
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
CLINITEST
diagnostic reagents and chemicals for clinical and medical use, namely, medical diagnostic reagents and assays for testing of body fluids medical diagnostic test kit comprising of pipettes and test cassettes for identification of the SARS-CoV-2 virus in humans; medical diagnostic instruments, namely, medical diagnostic instruments for the analysis of body fluids
Classification Information
Class [005]
Pharmaceutical Products
diagnostic reagents and chemicals for clinical and medical use, namely, medical diagnostic reagents and assays for testing of body fluids
First Use Date in General
27th Jan 1941
First Use Date in Commerce
27th Jan 1941
Class [010]
Medical Instrument Products
medical diagnostic test kit comprising of pipettes and test cassettes for identification of the SARS-CoV-2 virus in humans; medical diagnostic instruments, namely, medical diagnostic instruments for the analysis of body fluids
First Use Date in General
10th Oct 2020
First Use Date in Commerce
01st Oct 2021
Mark Details
Serial Number
No 90976382
Mark Type
No Service/Collective Mark
Attorney Docket Number
No 2020W20490US
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 12th Apr 2022 | REGISTERED-PRINCIPAL REGISTER |
| 10th Mar 2022 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 09th Mar 2022 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 26th Jan 2022 | STATEMENT OF USE PROCESSING COMPLETE |
| 26th Jan 2022 | DIVISIONAL PROCESSING COMPLETE |
| 21st Jan 2022 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 07th Jan 2022 | USE AMENDMENT FILED |
| 07th Jan 2022 | DIVISIONAL REQUEST RECEIVED |
| 07th Jan 2022 | TEAS REQUEST TO DIVIDE RECEIVED |
| 07th Jan 2022 | TEAS STATEMENT OF USE RECEIVED |